文献速递乳房整形与再造

同期与延期对侧乳房对称化手术的安全性:系统综述与meta分析

The safety of simultaneous versus delayed contralateral breast symmetrization: Systematic review and meta-analysis.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2025-04-22

同期组总体并发症合并发生率为17%、再手术率为28%;在对比研究中,同期与延期组在总体并发症、血肿、坏死和再手术方面均无显著差异(P值均>0.05)。结论认为同期对称化与延期对称化并发症及再手术率相似。

要点

  • 同期对称化组总体并发症合并发生率17%,再手术率28%。
  • 同期与延期组在总体并发症、血肿、坏死、再手术上无显著差异(P>0.05)。
  • 结论支持同期对称化在乳房再造中的相对安全性,供医患共同决策参考。

核心结论

  • 同期对称化的并发症与再手术率与延期对称化相似。
  • 该结论支持同期对称化在乳房再造中的相对安全性,并为医患共同决策提供额外数据。

研究设计与样本

  • 系统综述与meta分析,遵循PRISMA指南,检索PubMed、Embase和Scopus数据库。
  • 对称化术式包括缩乳(36%)、乳房固定(28%)、隆乳(12%)、隆乳-乳房固定(3%)、缩乳-乳房固定(2%)及未指明(19%)。
  • 再造类型包括自体皮瓣再造(n=1038)和假体再造(n=225)。

主要发现

  • 同期对称化组总体并发症合并发生率为17%,再手术合并发生率为28%。
  • 在对比同期与延期组的研究中,总体并发症、血肿、坏死和再手术均无显著差异(P值均>0.05)。

临床怎么用

  • 同期对称化与延期对称化并发症及再手术率相似,可作为医患共同决策时考虑的相对安全选项。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While unilateral breast reconstruction often requires contralateral breast symmetrization procedures, the optimal timing of the matching procedure remains unclear. While the delayed approach may be traditionally perceived as safer, the immediate or simultaneous approach may reduce additional operations and avoid a period of breast asymmetry. This study investigates and compares the safety outcomes associated with simultaneous and delayed contralateral symmetrization. METHODS: A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Embase, and Scopus databases were queried to identify studies reporting safety outcomes in breast reconstruction patients who had received simultaneous and/or delayed contralateral symmetrization. Meta-analyses estimated the pooled complication and reoperation rates of the simultaneous group and compared the complication and reoperation rates between the simultaneous and delayed groups. RESULTS: Eleven studies with a total of 1263 patients were included, with 697 receiving simultaneous symmetrization and 566 receiving delayed symmetrization. Symmetrization procedures included reduction (36%), mastopexy (28%), augmentation (12%), augmentation-mastopexy (3%), reduction-mastopexy (2%), or unspecified (19%). The reconstruction types included autologous flap-based reconstruction (n = 1038) and implant-based reconstruction (n = 225). The pooled overall complication and reoperation rates of the simultaneous group were 17% and 28%, respectively. In studies comparing the simultaneous and delayed groups, there were no significant differences in overall complications, hematoma, necrosis, and reoperations (P-values > 0.05). CONCLUSION: Simultaneous symmetrization had similar complication and reoperation rates compared to delayed symmetrization. This conclusion supports the relative safety of simultaneous symmetrization in breast reconstruction and gives the surgeon and patient additional data to consider in their shared decision-making process.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Wang CY, Montalmant KE, Peng T, et al. The safety of simultaneous versus delayed contralateral breast symmetrization: Systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2025. PMID: 40344807. doi:10.1016/j.bjps.2025.04.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。